随着时间的推移,抗精神病药物多药学:证据表明交叉定位陷
Marc W H Lochmann van Bennekom, Harm J Gijsman1, Joanna IntHout2
1Dimence Mental Healthcare, Deventer, The Netherlands.
Journal of clinical psychopharmacology
|October 18, 2024
概括
抗精神病药物多药 (APP) 往往是为切换药物而启动的,但许多情况下会导致未完成的交叉标配. 一般来说,APP的原因仍然存在,特别是在治疗耐火性方面.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 抗精神病多药 (APP) 是一种常见但有争议的实践,在约20%的精神病患者中使用.
- 调查启动和继续APP的原因对于优化患者护理和减少不适当的药物使用至关重要.
研究的目的:
- 确定在住院患者中启动和延续抗精神病多种药物 (APP) 的主要指示.
- 评估未完成的交叉标题对APP持续存在的贡献.
主要方法:
- 一项长达2个月的前性研究,涉及55名被诊断患有精神病,主要是精神分裂症的住院患者.
- 处方者在开始APP和30和60天后进行了调查,以确定指示 (例如,切换,镇静,治疗折射性) 和跟踪APP的延续.
- 测量的二次结果是60天后未完成的交叉标配的发生.
主要成果:
- 切换抗精神病药物是APP最常见的初始适应症 (56%),其次是镇静 (22%) 和治疗折射性 (18%).
- 45%的患者在30天后停止使用APP,60%的患者在60天后停止使用APP.
- 在60天后,用于切换抗精神病药物的APP在29%的病例中仍在进行,66%的病例中处于镇静状态,90%的病例中处于治疗阻断状态. 未完成的交叉标配发生在29%的患者中,他们的APP已开始切换.
结论:
- 抗精神病药物多药 (APP) 经常是为了切换抗精神病药物而启动的,其中很大一部分 (29%) 导致未完成的交叉标配.
- 在60天的研究期间,APP的初始适应症往往保持在60天的研究期间,特别是当原因是治疗折射性时.
- 这项研究强调了需要仔细管理抗精神病药物切换,以避免长期或不适当的APP.
相关概念视频
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
Psychosis and Antipsychotic Drugs: Overview
183
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
183
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
90
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
90
Antipsychotic Drugs: Typical and Atypical Agents
159
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
159


